Company / SG&A per Share
Chemed Corp. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$27.45
FY2025
5-year range
$21.88 / $28.11
FY2021-FY2025
Trend
-2.3%
vs FY2024
Sector context
#11 of 150
Health Care
What the data says
Among 150 Health Care companies, Chemed Corp. is in the bottom 7% for sg&a per share. SG&A per Share has fluctuated over the past 10 years, ranging from $13.65 in FY2016 to $28.11 in FY2024.
Based on SEC 10-K filings.
27.45 in FY2025 with a 5-year CAGR of +6.9%. Top quartile in the Health Care sector.
Increased from $24.79 to $27.45 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +7.9%
- 5-Year CAGR
- +6.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 150This company $27.45 Sector average $11878.17
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 2.3% year-over-year.
- Ranks #11 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.45 | -2.3% |
| FY2024 | $28.11 | +13.4% |
| FY2023 | $24.79 | +13.3% |
| FY2022 | $21.88 | -1.4% |
| FY2021 | $22.19 | +12.9% |
| FY2020 | $19.65 | +7.6% |
| FY2019 | $18.26 | +13.0% |
| FY2018 | $16.15 | +1.7% |
| FY2017 | $15.88 | +16.3% |
| FY2016 | $13.65 | +6.7% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026